Relative Strength Chart MannKind Corporation
Equities
MNKD
US56400P7069
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.610 USD | -2.61% |
|
-10.77% | -53.97% |
| 03-05 | MannKind Reports Convertible Notes Settlement | MT |
| 03-05 | Wedbush Adjusts Price Target on MannKind to $8 From $10, Maintains Outperform Rating | MT |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MANNKIND CORPORATION | Bio Therapeutic Drugs | -2.61% | -10.77% | -53.97% | -47.70% | -32.21% | 804M |  | | |
- Stock Market
- Equities
- MNKD Stock
- Charts MannKind Corporation
- Relative Strength Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition